Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Next Deadline
130 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
November 23, 2025
Extension Available
Until May 23, 2024
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 9, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 8, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 20, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 20, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 23, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 23, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 16, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 14, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 14, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 14, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 23, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 18, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 4, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 4, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 1, 2023 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | Loading... |
| Feb 1, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 1, 2023 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Feb 1, 2023 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Feb 1, 2023 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Jan 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 12, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
Class 009
Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Class 041
Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Class 042
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
Class 044
Providing medical information in the fields of genetic medicine and drug delivery
Classification
International Classes
005
009
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"